EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 24th, 2017 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
THIS EMPLOYMENT AGREEMENT (the "Agreement"), effective as of October 27, 2016, is entered into by Momenta Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 675 West Kendall Street, Cambridge, Massachusetts (the "Company"), and Scott M. Storer, an individual residing at XXX (the "Employee").
INDUSTRY CONSULTING AGREEMENTIndustry Consulting Agreement • February 24th, 2017 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS INDUSTRY CONSULTING AGREEMENT (“Agreement”) is made and entered into as of the 30th day of December, 2016 (the “Effective Date”) by and between MOMENTA PHARMACEUTICALS, INC., a Delaware corporation, having a place of business at 675 West Kendall Street, Cambridge, MA 02142 (“Company”) and Richard P. Shea, having a place of business at XXX (“Consultant”).
ASSET RETURN AND TERMINATION AGREEMENTAsset Return and Termination Agreement • February 24th, 2017 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
This Asset Return and Termination Agreement (this “Agreement”), effective as of December 31, 2016 (the “Effective Date”), is made by and between Momenta Pharmaceuticals, Inc., a Delaware corporation (“Momenta”), Baxalta Incorporated, a Delaware corporation (“BI”), Baxalta US Inc., a Delaware corporation (“BUSI”), and Baxalta GmbH, a Swiss corporation (“BGMBH” and, together with BI and BUSI, collectively, “Baxalta”). Momenta and Baxalta are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
